Author

A. Jayakumar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:metagenomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

A. R. Babbin· 2 shared B. B. Ward· 2 shared I. H. Zhang· 2 shared R. Zhao· 1 shared S. G. Fortin· 1 shared X. Sun· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. R. Babbin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Origin, age, and metabolisms of dominant anammox bacteria in the global oxygen deficient zones

R. Zhao, I. H. Zhang, A. Jayakumar, B. B. Ward, A. R. Babbin

The paper identifies two novel Scalindua genomes from oxygen deficient zones, revealing their metabolic versatility and evolutionary adaptation to anoxic environments.

bioRxiv · Oct 31, 2023 · PreprintMicrobiology

Genome-resolved metagenomics reveals abundant nitrate reducers and partitioning of nitrite usage within global oxygen deficient zones

I. H. Zhang, X. Sun, A. Jayakumar, S. G. Fortin, B. B. Ward, A. R. Babbin

The paper uses genome-resolved metagenomics to analyze 56 ODZ metagenomes, revealing that partial denitrifiers dominate nitrogen cycling and showing niche differentiation among nitrogen-cycling organisms.

bioRxiv · Mar 2, 2023 · PreprintMicrobiology

RIPK3 inhibition prevents KRAS mutant p53 deficient lung tumor progression by impeding MDSCs

A. Jayakumar

This study shows that RIPK3 inhibition in MDSCs reduces KP NSCLC tumor growth and enhances immunotherapy effectiveness.

bioRxiv · Nov 25, 2019 · PreprintCancer Biology